Memory impairments, spatial disorientation, apathy, and sleep disorders were the commonly found residual symptoms in anti‐LGI1 patients, whereas memory impairments and seizures were common in anti‐GABABR patients. The gene discussed is LGI1; the disease is memory impairment.